Side skin reactions of multikinase inhibitors in treatment of thyroid cancer von Sevryukov, F. S., Borodavina, E. V., Isaev, Р. А., Polkin, V. V., Ilyin, А. А., Vasilkov, S. V., Panaseykin, Yu. А., Derbugov, D. N., Ivanov, S. А., Podvyaznikov, S. О., Kaprin, А. D.

Volltext

A randomized study to evaluate the safety and efficacy of two dosages of lenvatinib – 18 and 24 mg – in patients with radioiodrefract differentiated thyroid cancer von Brose, M. S., Panaseykin, Yu, Konda, B., De la Fouchardiere, C., Hughes, B. G.M., Gianoukakis, A. G., Park, Y. J., Romanov, I., Krzyzanowska, M. K., Leboulleux, S., Binder, T. A., Dutcus, C., Xie, R., Taylor, M. H.

Volltext

CHEMORADIOTHERAPY FOR ORAL CANCER USING HYPERFRACTIONATED RADIATION SCHEDULE von Radzhapova, M. U., Gulidov, I. A., Sevryukov, F. E., Mardynsky, Yu. S., Panaseykin, J. A., Semenov, A. V., Ivanov, S. A., Kaprin, A. D.

Volltext